Axsome Therapeutics (NASDAQ:AXSM) Stock Consolidate After The Rally: What Next?
More often than not, it is pretty tough for biotech companies to take their products to phase 3 of clinical trials and beyond. However, Axsome Therapeutics Inc (NASDAQ:AXSM) has proven to be an outlier in […]